Mathew Jones

ORCID: 0000-0001-7334-3723
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Acute Ischemic Stroke Management
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Venous Thromboembolism Diagnosis and Management
  • Sepsis Diagnosis and Treatment
  • Epilepsy research and treatment
  • Diabetes Management and Research
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Hemodynamic Monitoring and Therapy
  • Nosocomial Infections in ICU
  • Neurosurgical Procedures and Complications
  • Bacterial Infections and Vaccines
  • Neurological and metabolic disorders
  • Neonatal and fetal brain pathology
  • Long-Term Effects of COVID-19
  • Hepatitis Viruses Studies and Epidemiology
  • Cytomegalovirus and herpesvirus research
  • Acute Myocardial Infarction Research
  • EEG and Brain-Computer Interfaces
  • COVID-19 and Mental Health
  • Hepatitis C virus research
  • Intensive Care Unit Cognitive Disorders
  • Cerebrospinal fluid and hydrocephalus
  • Mechanical Circulatory Support Devices

Henry Ford Hospital
2013-2023

Methodist University Hospital
2020

University of Tennessee at Knoxville
2020

University of Tennessee Health Science Center
2017

Beth Israel Deaconess Medical Center
2017

University General Hospital Attikon
2017

National and Kapodistrian University of Athens
2017

Duke Medical Center
2016

Medical University of South Carolina
2016

Wayne State University
2012

Background: Since the approval of oral factor Xa inhibitors, there have been concerns regarding ability to neutralize their anticoagulant effects after intracranial hemorrhage (ICH). Multiple guidelines suggest using prothrombin complex concentrates (PCCs) in these patients on basis research that includes a limited number with ICH. Given this, we aimed evaluate safety and efficacy PCCs for inhibitor–related ICH large, multicenter cohort patients. Methods: This was multicenter, retrospective,...

10.1161/circulationaha.120.045769 article EN Circulation 2020-04-08

Purpose The purpose of this project was to characterize the use heart failure medications during first year after left-ventricular assist device (LVAD) implantation. Methods All patients who received a HeartMate II at our institution between January 1, 2007, and August 2009, were followed by multidisciplinary team for least 6 months eligible inclusion. Use medications, including dosages, collected each patient prior LVAD implantation, time discharge, subsequent monthly office visit up 1...

10.5301/ijao.5000068 article EN The International Journal of Artificial Organs 2012-03-01

The Centers for Medicare and Medicaid Services Severe Sepsis Septic Shock Management Bundle (SEP-1) assesses antibiotic administration, lactate measurement, blood culture collection within 3 h of severe sepsis onset. impact the SEP-1 3-hour bundle among patients with is not extensively described. This investigation aimed to describe compliance on 28-day in-hospital mortality in sepsis.This was a retrospective, propensity adjusted, nested case-control study assessing conducted at large,...

10.1002/phar.2715 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2022-07-01

Journal Article Indomethacin for treatment of refractory intracranial hypertension secondary to acute liver failure Get access Mathew C. Jones, Pharm.D., BCPS, BCPS Clinical Pharmacy Specialist Neurointensive Care, Department Pharmacy, Henry Ford Hospital, Detroit, MI Address correspondence Dr. Jones (mjones18@hfhs.org). Search other works by this author on: Oxford Academic Google Scholar Tracey Lasak-Myall, ATC, ATC Associate Medical Scientific Liaison Allergan, Inc., Irvine, CA Tamer M....

10.2146/ajhp140539 article EN American Journal of Health-System Pharmacy 2015-05-29

BACKGROUND: Intraventricular central nervous system (CNS) infections possess a significant associated morbidity and mortality. There are multiple conflicting opinions as to the relevance of intrathecal (IT) antibiotics, particularly regarding benefit versus potential harm with side effects administration. OBJECTIVE: We present review ten cases use IT antibiotics for management intraventricular infections. METHODS: Retrospective case series patients who received in combination systemic...

10.1212/wnl.84.14_supplement.p6.033 article EN Neurology 2015-04-06

Background: Anticoagulation reversal is recommended for patients with intracerebral hemorrhage (ICH) on vitamin K antagonists or novel anticoagulants. Guidelines vary and standardized protocols are inconsistent. While our institution has guidelines indicating appropriate products reversal, no specific timeline indicated. ICH volume known to increase by approximately 38[percnt] within the first 3 hours. Increase in size may be heightened anticoagulation without timely reversal. Objective:...

10.1212/wnl.86.16_supplement.i6.004 article EN Neurology 2016-04-05

We report the result of checking a scoring system for neonatal seizures in which information from EEG, etiology, neurological examination, seizure type and birth weight are combined to predict sequelae make decisions about treatment. The results two samples presented compared. first sample included 96 neonates; 103 neonates were evaluated second sample, yielding data 199 samples.The served separate who had at age 10 months or more those did not. In addition, provided an excellent guide...

10.1055/s-2008-1052517 article EN Neuropediatrics 1986-08-01

Horng, Michelle1; Smith, Zach1; Jones, Mathew1; Peters, Michael2; Kalus, James1 Author Information

10.1097/01.ccm.0000458119.99438.f1 article Critical Care Medicine 2014-11-18

Background: Anticoagulation reversal is recommended for patients with intracerebral hemorrhage (ICH) on vitamin K antagonists or novel anticoagulants. Guidelines vary and standardized protocols are inconsistent. While our institution has guidelines indicating appropriate products reversal, no specific timeline indicated. ICH volume known to increase by approximately 38[percnt] within the first 3 hours. Increase in size may be heightened anticoagulation without timely reversal. Objective:...

10.1212/wnl.86.16_supplement.s16.008 article EN Neurology 2016-04-05

Introduction: The purpose of this study was to assess the impact implementation a norepinephrine (NE) dosing protocol on time hemodynamic stabilization in patients with septic shock. Methods: This quasi-experimental study, utilizing 1-group pretest-posttest design. It included adult shock who received NE Medical Intensive Care Unit at our institution between 10/2012 and 5/2013. Patients were grouped based whether they pre- or post-implementation protocol. primary outcome difference...

10.1097/01.ccm.0000440142.32717.19 article EN Critical Care Medicine 2013-11-26

Introduction: Intravenous (IV) acyclovir is known to cause crystal-induced acute kidney injury (AKI). The risk of AKI can be reduced by providing adequate hydration during therapy, but the necessary fluid volume prevent in this setting remains unclear. Due risk, our practice site has implanted an order panel that includes continuous IV isotonic crystalloids when ordering acyclovir. purpose study was evaluate prevalence acyclovir-induced and characterize utilization fluids, with without...

10.1097/01.ccm.0001000244.53154.bb article EN Critical Care Medicine 2023-12-14
Coming Soon ...